Jan Marsal
Project owner · Associate Professor · Gastroenterologist
Jan leads the clinical and research direction of IBDi. His work focuses on proactive remote monitoring and management of inflammatory bowel disease using digital health tools.
About
Built close to IBD care
IBDi is being developed to address a practical clinical challenge: IBD care needs better visibility between scheduled visits, without increasing unnecessary burden for patients or clinical teams.
Why IBDi exists
A clinical problem, not a startup myth
The project brings together clinical care, research, product development, and implementation thinking. The current platform is already used in live clinical studies, and the next phase is focused on improving the product, strengthening the evidence base, and preparing for broader implementation carefully.
The goal is to build better monitoring infrastructure for IBD: not just another app.
Team
People close to IBD care, research, and implementation
IBDi is developed by a clinical, research, and product team working close to real inflammatory bowel disease care. The project combines gastroenterology expertise, clinical research, implementation thinking, and digital product development.
Tillmann Raith
Gastroenterologist · PhD student
Tillmann contributes to the clinical research and study development behind IBDi, including the work to evaluate remote monitoring, home-based testing, and new care workflows in IBD.
Vidar Christiansen
Project and technology lead
Vidar leads the product and technology development of IBDi, connecting clinical needs, patient experience, app development, and implementation planning.
Built from clinical reality
IBDi is not being developed as a generic wellness app. It is shaped by people working across IBD care, clinical research, product development, and implementation: with the goal of building a practical monitoring platform that can be studied, improved, and eventually scaled responsibly.
How we work
Clinical anchoring
The platform is shaped by real IBD care, not abstract digital-health ambition.
Evidence first
We build evidence through live clinical studies before broader claims.
Careful governance
Future features that influence clinical decisions require validation and regulatory review.
Current boundaries and future direction
Current
Current boundaries
- Used in live clinical studies
- Not CE marked
- No autonomous diagnosis, prediction, or treatment recommendations
- Clinician-reviewed follow-up only
Roadmap
Future evidence direction
- Phase 2 product refinement
- Improved UX and richer data
- Analytics after validation
- Broader implementation when ready
Want to talk to the team?
For clinical, research, or implementation conversations, get in touch.